Underwood M A, Danielsen B, Gilbert W M
Department of Pediatrics, University of California Davis School of Medicine, Davis, CA, USA.
J Perinatol. 2007 Oct;27(10):614-9. doi: 10.1038/sj.jp.7211801. Epub 2007 Aug 23.
To examine hospital readmissions for premature infants during the first year of life.
The California maternal and newborn/infant hospital discharge records were examined for subsequent readmission during the first year of life for all newborns from 1992 to 2000. Discharge diagnoses, hospital days, demographic data and hospital charges for infants born preterm (<36 weeks gestation) were identified and evaluated.
About 15% of preterm infants required at least one rehospitalization within the first year of life (average cost per readmission 8,468 dollars, average annual cost in excess of 41 million dollars). Infants with gestational age <25 weeks had the highest rate of readmission (31%) and longest average length of stay (12 hospital days). The largest cohort, infants born at 35 weeks gestation, had the highest total cost of readmission (92.9 million dollars). The most common cause of rehospitalization was acute respiratory disease. There was no decrease in the number or cost of readmissions of premature infants for respiratory syncytial virus infections following the introduction of palivizumab in 1998.
After initial discharge, premature infants continue to have significant in-patient health-care needs and costs.
研究早产儿出生后第一年的再次入院情况。
查阅1992年至2000年加利福尼亚州所有新生儿的母婴及新生儿出院记录,以了解其出生后第一年的再次入院情况。确定并评估早产(孕周<36周)婴儿的出院诊断、住院天数、人口统计学数据及住院费用。
约15%的早产儿在出生后第一年至少需要再次住院一次(每次再次住院平均费用为8468美元,每年总费用超过4100万美元)。孕周<25周的婴儿再次入院率最高(31%),平均住院时间最长(12天)。最大的一组是孕周为35周出生的婴儿,其再次住院的总费用最高(9290万美元)。再次住院最常见的原因是急性呼吸道疾病。1998年引入帕利珠单抗后,早产儿因呼吸道合胞病毒感染再次入院的人数及费用并未减少。
首次出院后,早产儿仍有大量的住院医疗需求及费用。